| AA | Acrylic acid |
| ALP | Alkaline phosphatase |
| BMP2 | Bone morphogenetic protein 2 |
| Coll1 | Collagen type I |
| CM | Complete medium, i.e., DMEM with 10% FBS |
| DM | Differentiating medium, i.e., DMEM supplemented with the osteogenic factors: dexamethasone, ascorbic acid and β-glycerophosphate |
| DMEM | Dulbecco’s modified Eagle’s medium |
| DPPH assay | 2,2-difenil-1-picrylhydrazyl assay |
| FBS | Fetal bovine serum |
| FoxO | Forkhead box O |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase |
| GUSB | Beta-glucuronidase |
| HPLC | High-performance liquid chromatography |
| MSCs | Mesenchymal stem cells |
| MTT | 3-dimethylthiazol-2,5-diphenyltetrazolium bromide |
| OB | Osteoblasts |
| ON | Osteonectin–protein |
| PDPCs | Periosteal-derived precursor cells |
| PEGDA | Poly(ethylene-glycol diacrylate) |
| PEGDA-AA | Poly(acrylic acid)–poly(ethylene-glycol diacrylate) coating |
| PEGDA-AA/Arb AE | Poly(acrylic acid)–poly(ethylene-glycol diacrylate) coating with arbutin embedded after electrosynthesis |
| PEGDA-AA/Arb DE | Poly(acrylic acid)–poly(ethylene-glycol diacrylate) coating with arbutin embedded during electrosynthesis |
| RANK-L | Receptor activator of nuclear factor kappa-Β ligand |
| RSA % | Radical scavenging activity percentage |
| ROS | Reactive oxygen species |
| RUNX-2 | Runt-related transcription factor 2 |
| Saos-2 | Human osteosarcoma cell line |
| SEM | Scanning electron microscopy |
| Sparc | Secreted protein, acidic, cysteine-rich–osteonectin gene |
| TCF | T-cell factor |
| TGA | Thermogravimetric analysis |
| XPS | X-ray photoelectron spectroscopy |
| Wnt | Wingless-related integration site |